Fulgent Genetics, Inc. Investigated by the Portnoy Law Firm
Globe Newswire (Fri, 13-Mar 9:00 AM ET)
Globe Newswire (Thu, 12-Mar 2:06 PM ET)
PRNewswire (Thu, 12-Mar 10:07 AM ET)
PRNewswire (Thu, 5-Mar 5:07 PM ET)
Globe Newswire (Mon, 2-Mar 1:10 PM ET)
Market Chameleon (Fri, 27-Feb 3:19 AM ET)
Fulgent Reports Fourth Quarter and Full Year 2025 Financial Results
Business Wire (Fri, 27-Feb 7:00 AM ET)
Fulgent to Announce Fourth Quarter and Full Year 2025 Financial Results on Friday, February 27, 2026
Business Wire (Thu, 12-Feb 7:30 AM ET)
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.
Fulgent Genetics trades on the NASDAQ stock market under the symbol FLGT.
As of March 16, 2026, FLGT stock price climbed to $14.95 with 857,249 million shares trading.
FLGT has a beta of 0.71, meaning it tends to be less sensitive to market movements. FLGT has a correlation of 0.05 to the broad based SPY ETF.
FLGT has a market cap of $462.14 million. This is considered a Small Cap stock.
Last quarter Fulgent Genetics reported $83 million in Revenue and $.16 earnings per share. This fell short of revenue expectation by $-2 million and exceeded earnings estimates by $.25.
In the last 3 years, FLGT traded as high as $44.09 and as low as $13.46.
The top ETF exchange traded funds that FLGT belongs to (by Net Assets): VTI, IWM, VXF, FNDA, IWN.
FLGT has underperformed the market in the last year with a price return of -12.0% while the SPY ETF gained +22.6%. FLGT has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -44.9% and -2.5%, respectively, while the SPY returned -1.6% and -2.5%, respectively.
FLGT support price is $14.38 and resistance is $15.17 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that FLGT shares will trade within this expected range on the day.
